You are 3 steps away
from making better decisions

Serving leading biopharmaceutical companies globally:

Johnson and Johnson
Express Scripts
Harvard Business School

Last Updated: July 3, 2020

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 063067

Email this page to a colleague

» See Plans and Pricing

« Back to Dashboard

NDA 063067 describes DYNACIN, which is a drug marketed by Cnty Line Pharms and is included in one NDA. It is available from three suppliers. Additional details are available on the DYNACIN profile page.

The generic ingredient in DYNACIN is minocycline hydrochloride. There are fifteen drug master file entries for this compound. Thirty-nine suppliers are listed for this compound. Additional details are available on the minocycline hydrochloride profile page.
Summary for 063067
Applicant:Cnty Line Pharms
Ingredient:minocycline hydrochloride
Formulation / Manufacturing:see details
Pharmacology for NDA: 063067
Medical Subject Heading (MeSH) Categories for 063067
Suppliers and Packaging for NDA: 063067
Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
DYNACIN minocycline hydrochloride CAPSULE;ORAL 063067 ANDA Alvogen, Inc. 47781-544 47781-544-01 100 CAPSULE in 1 BOTTLE (47781-544-01)
DYNACIN minocycline hydrochloride CAPSULE;ORAL 063067 ANDA Alvogen, Inc. 47781-545 47781-545-01 100 CAPSULE in 1 BOTTLE (47781-545-01)

Profile for product number 001

Active Rx/OTC/Discontinued:RXDosage:CAPSULE;ORALStrengthEQ 100MG BASE
Approval Date:Jul 31, 1990TE:ABRLD:No

Profile for product number 002

Active Rx/OTC/Discontinued:RXDosage:CAPSULE;ORALStrengthEQ 75MG BASE
Approval Date:Sep 15, 1999TE:ABRLD:No

Profile for product number 003

Active Rx/OTC/Discontinued:RXDosage:CAPSULE;ORALStrengthEQ 50MG BASE
Approval Date:Aug 14, 1990TE:ABRLD:No

Complete Access Available with Subscription

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Express Scripts
Harvard Business School
Johnson and Johnson

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.